研究单位：[1]Liyuan Hospital of Tongji Medical College,Huazhong University of Science and Technology[2]Zibo Feng Wuhan,Hubei,China,430000[3]Xuanwu Hospital Capital Medical University Beijing,China[4]Hospital of Chengdu University of Traditional Chinese Medicine Chengdu,China[5]Hangzhou First People's hospital of Medical College of Zhejiang University Hangzhou,China[6]the First Affiliated hospital of Medicine College of Zhejiang University Hangzhou,China[7]Qingdao Haici hospital affiliated to Qingdao University Qingdao,China[8]Renji Hospital of Shanghai Jiaotong University Shanghai,China[9]Zhongshan Hospital of Fudan University Shanghai,China[10]the second Affiliated Hospital of Medical College of Suzhou University Suzhou,China
研究目的：
There have been a number of randomized controlled studies (RCT) showing the efficacy of the endovascular treatment with drug-coated balloons (DCB) in the femoropopliteal artery lesions. However, these studies have been carefully designed, and most of them have excluded long-length lesions and severely calcified lesions. In addition to being used alone in the real word, drug-coated balloons (DCB) are also used in combination with stents or debulking devices, but in these randomized controlled studies (RCT) they are only compared with standard percutaneous transluminal angioplasty (PTA). Therefore, the investigators initiated this study, which is a prospective, multicenter, observational real-world study of short and long-term outcome in endovascular treatment of femoropopliteal arterial occlusive lesions with DCB.
